ESCRS - Supplement: Easing the Marathon Glaucoma Patient Journey with iStent inject® W ;
ESCRS - Supplement: Easing the Marathon Glaucoma Patient Journey with iStent inject® W ;
Supplements

Supplement: Easing the Marathon Glaucoma Patient Journey with iStent inject® W

Supplement: Easing the Marathon Glaucoma Patient Journey with iStent inject® W

This supplement shares technical tips on taking the first step with iStent inject® W, improving the benefit to risk ratio, and improving quality of life on the glaucoma journey.

Tags: glaucoma
Latest Articles
Glaucoma Treatment Under Pressure

New techniques and technologies add to surgeons’ difficult decisions

Read more...

Outside the Box, Inside the Pipeline

Researchers are tackling glaucoma diagnosis and treatment from all sides.

Read more...

The EHDS Is Ready for the Green Light

If proposal is approved, Europe could see better access to, and exchange and use of, health data.

Read more...

From Lab to Life: Corneal Repair Goes Cellular

Long-awaited cellular therapies for corneal endothelial disease enter the clinic.

Read more...

Balancing Innovation and Safety

Ensuring access to advanced cell therapies amid regulatory overhaul.

Read more...

With Eyes on Its Future, ESCRS Celebrates Its Past

Winter Meeting offers opportunities to experiment with new concepts and formats.

Read more...

Best of ESCRS Winter Meeting 2024

Read more...

Following the New Generation

EDOF IOLs an option for eyes with mild comorbidities, showing potential in mini-monovision strategies.

Read more...

Refocus on Multifocals

Trifocal IOLs continue to improve as consensus grows regarding indications and contraindications.

Read more...

Common Myths in Presbyopia Correction

Patient education key to satisfaction with refractive IOLs.

Read more...

;